Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
14 active Medicare policies list N93.8, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
5 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of N93.8 |
|---|---|---|
| Endometrial Cancer Screening, Diagnosis, and Prognosis | Oct 26, 2023 | Covered |
| Gonadotropin-Releasing Hormone Analogs and Antagonists | Jul 14, 2023 | Covered |
| Policy | Effective | Status of N93.8 |
|---|---|---|
| Endometrial Ablation | Not recorded | Covered |
| Testing for Select Genitourinary Conditions | Not recorded | Covered |
J8 · Effective Apr 17, 2022
J6 · Effective Apr 1, 2026
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
| Policy | Effective | Status of N93.8 |
|---|---|---|
| Hysterectomy | Jul 1, 2026 | Covered |